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S U M M A R Y 
A sample of 1,288 inhabitants of Salvador, Bahia, Brazil, were submitted to 
the determination of anti-HBs using radioimmunoassay procedure, and analysed 
according to age, sex and income. Overall prevalence of anti-HBs was 11,8%. 
ranging from 6,7% among children aged less than three years old to 26,1% 
among those aged 30 years and older. Males presented prevalence of anti-HBs 
similar to female individuals, and those with a higher income showed frequencies 
of anti-HBs greater than those with a lower income level. The following con-
clusions were drawn: The high prevalence of anti-HBs observed among children 
suggests early contact with hepatitis B virus, possibly due to vertical trans-
mission and intrafamiliar dissemination of the disease; the frequency of anti-HBs 
increases with age; the lower prevalence of anti-HBs among those with low 
income suggests that this group may present higher prevalence of carriers of 
the hepatitis B virus surface antigen. 
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I N T R O D U C T I O N 
The infection to hepatitis B virus presents 
a worldwide distribution, although it is more 
prevalent in less developed countries of tropical 
and subtropical areas 1,3,4,11,14,20 than in more 
developed countries 12.19. Its relationship to the 
general socio-economic status of the population 
is better shown through the distribution of 
prevalence rates of hepatitis B virus markers 
according to the social classes within a 
country 15,17,18. 
The presence of antibody to the hepatitis B 
virus surface antigen (anti-HBs) is indicative 
of past infection and represents acquired im-
munity. Therefore, the epidemiologic value of 
determining the prevalence of anti-HBs is relat-
ed to the understanding of transmission dyna-
mics and the estimation of the susceptible 
population, aimed at planning controls pro-
grams. . 
Population-based studies describing the epi-
demiologic characteristics of the prevalence 
and distribution of anti-HBs in Brazil are lack-
ing. This report describes the age and sex dis-
tribution of the prevalence of anti-HBs, accord-
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ing to the socio-economic status of a defined 
population in Northeast Brazil. 
MATERIALS AND METHODS 
The study was carried out during 1981 and 
1982 among residents of the city of Salvador-
state of Bahia, an urban area of little over 
1,500,000 inhabitants. The study group compris­
ed a sample of 1,345 individuals. Participants 
were selected randomly among children attend­
ing public and private schools and among adults 
seen at private and public physicians'offices 
and clinical laboratories throughout the city. 
Blood samples were collected by venipunc­
ture, and the sera obtained after centrifugation 
were stored at — 20°C freezer temperature. De­
termination of the presence of anti-HBs was 
performed by the radioimunoassay method, 
using standard procedure recomended for 
AUSAB reagents (ABBOTT Laboratories). 
Each serum sample was tested for tran­
saminases before the determination of anti-
HBs and those individuals with elevated levels 
of transaminases (> 50 units, Reitman and 
Frankel method) were excluded from the study. 
This procedure was adopted in order to avoid 
the participation of individuals with potential 
liver disease, excluding from analysis some 57 
sera samples. Further criteria for exclusion 
were the presence of jaundice or a diagnosis 
Individuals classified as part of group I. 
representing in this study a better socio-eco­
nomic status, had an overall prevalence rate 
of anti-HBs of 13.9%, in contrast to a rate 
of 9.4% observed for individuals in the group 
of liver disease at the moment of the clinical 
examination. 
Information were collected from each par­
ticipant on age, sex, educational level, occupa­
tion and income. On the basis of the total 
family income level, participants were divided 
into two groups: group I comprising those 
members of families with less than five persons 
and total family income equal to or more than 
US$ 170 per month, and group II formed by 
those individuals with a total family income 
of less than US 170 per month. 
RESULTS 
The total of 1,288 individuals included in 
the study presented an overall prevalence of 
anti-HBs of 11,8%. The proportion of those 
positive to anti-HBs increased from 6.7% for 
individuals aged less than three years, to a 
level of 26.1% for those aged more than 30 
years (Table 1). The overall prevalence rate of 
anti-HBs was similar for males and females, 
respectively, 11.76% and 11.84%. The age and 
sex distribution of positivity to and-HBs showed 
that females aged less than three years and 11 
to 14 years old presented a rate higher than 
males of the same age groups, in contrast to 
a rate higher in males than in females for 
those aged seven to ten years, although these 
differences were not statistically significant. 
II (Table 2), a difference that was statistically 
significant (X2 = 5.939, df = 1, p < 0.05). The 
prevalence rates of anti-HBs by sex were si­
milar for males and females within each in­
come level group. 
DISCUSSION 
The overall prevalence rate of anti-HBs of 
11.8% observed in Salvador is relatively low, 
however, this represents the frequency of anti-
HBs for a group of individuals of all ages. 
In fact, a study performed among blood donors 
in Brazil*5 observed prevalence of 26.7%, a 
rate that is similar to that found in our study 
for individuals aged more than 30 years. 
The gradual rise in the rate of positivity 
to anti-HBs by age is similar to that described 
in other populations2,". Moreover, the relati-
vely high rates found among children in Sal-
vador are comparable to those observed in 
areas where hepatitis B virus in highly en-
demic 7. This may reflect exposition to the virus 
in the first years of life, possibly due to ver-
tical transmission 1 3 4 6 and intrafamiliar disse-
mination of the infection. In fact, the risk of 
acquiring the infection during the perinatal 
period may be as high as 40% to 50% in 
areas where hepatitis B virus carriers are 
frequent 9 4 0 , 1 6 . This study showed that male 
and female individuals presented similar ove-
rall prevalence rates of anti-HBs. Serologic 
surveys carried out in different countries re-
vealed that males presented a higher prevalence 
of hepatitis B surface antigen carrier state than 
females His. However, other investigators have 
found a higher prevalence of anti-HBs among 
females than males 1 5 . 
It was observed a lower rate of anti-HBs 
among those of a lower socio-economic level. 
It is possible that the prevalence of hepatitis B 
virus carriers is higher in this group, decreas-
ing the number of those presenting anti-HBs. 
In fact, this group are exposed to a higher 
risk of acquiring hepatitis B virus earlier in 
life, with a consequently higher risk of develop-
ing the carrier state 7 . In addition, carriers of 
hepatitis B virus are more prone to develop 
liver disease including primary liver cancer or 
to develop antibody to hepatitis B only later 
in life5-8. Other studies are indicated to in-
crease the knowledge on the epidemiology of 
the disease in Brazil. 
RESUMO 
Prevalência de anticorpos contra o vírus da 
hepatite B em população urbana do nordeste 
brasileiro. 
Um grupo de 1.288 indivíduos, residentes 
em Salvador, Bahia, Brasil, foi examinado pa-
ra a determinação de anti-HBs, utilizando-se a 
técnica do radioimunoensaio. Os resultados fo-
ram analisados de acordo com a idade, o sexo 
e o nível de renda. Uma prevalência de anti-¬ 
HBs de 11,8% foi observada, variando de 6,7% 
nas crianças com idade inferior a três anos, 
a 26,1% para aqueles com idade superior a 30 
anos. A prevalência de anti-HBs foi similar em 
indivíduos do sexo masculino e feminino. Aque-
les com nível de renda mais alto tiberam pre-
valência de anti-HBs maior que o grupo de 
renda baixa. Dos resultados conclui-se: a alta 
prevalência de anti-HBs em crianças sugere o 
contato precoce com o vírus da hepatite B, 
possivelmente relacionado com a transmissão 
vertical e a disseminação intraíamiliar do ví-
rus; a freqüência de anti-HBs aumentou com 
a idade; a baixa prevalência de anti-HBs entre 
aqueles com baixo nível sócio-econômico su-
gere que neste grupo pode ser alta a prevalên-
cia de portadores do vírus B da hepatite. 
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